Encyclopedia
Comparisons~6 min read

AviClear® vs. Spironolactone: Which Is Right for You?

Two modern options for hormonally-driven acne take very different routes to the same goal — less oil, fewer breakouts. Here’s a fair comparison.

Requires clinician review before publishing — this comparison contains clinical claims.

For hormonally-driven acne, two modern options come up a lot: spironolactone, an oral anti-androgen medication with a long track record in women, and AviClear®, a laser that reduces oil production directly. They take very different routes to the same goal — less oil, fewer breakouts — and they suit different people.

The short version

Spironolactone is an oral medication that blocks androgen effects on the skin, with good evidence for treating hormonal acne in women and a generally mild side-effect profile — but it’s a daily pill, works only while you take it, isn’t used in men, and isn’t suitable in pregnancy. AviClear is an in-clinic laser that reduces oil production at the source, with no systemic effects, suitable across sexes and skin tones, and no daily medication — but it’s newer, costs out of pocket, and isn’t specifically a hormonal treatment.

How each one works

Spironolactone was originally a blood-pressure medication (a potassium-sparing diuretic) that also has anti-androgen properties. Since androgens drive oil production, blocking their effect on the skin reduces sebum and improves acne. It’s been used off-label for acne in women since the 1980s and is taken as a daily oral pill, typically in the range of 50–100 mg/day.

AviClear is a 1726 nm laser delivered in a series of in-clinic sessions that heats and downregulates the sebaceous glands, reducing oil production directly — regardless of what’s driving the oil. So both reduce oil, but spironolactone does it by countering hormones systemically, while AviClear does it by acting on the oil glands locally.

Effectiveness

Spironolactone has solid evidence for adult women with acne. Good-quality randomized trials support its effectiveness at 50–100 mg daily, meta-analyses show clear benefit over placebo, and observational data report substantial improvement for many patients. It’s particularly suited to hormonal-pattern acne along the jaw and chin. Its main limitation is that it works only while you keep taking it — stop, and acne can return.

AviClear has encouraging peer-reviewed data across skin types for mild-to-severe inflammatory acne, with improvement that builds and persists over the first year. Because it changes the oil glands themselves, its benefit is intended to be durable without ongoing maintenance — though it’s newer, with less long-term track record than spironolactone.

Side effects and safety

Spironolactone

  • Generally well tolerated, with mostly mild side effects.
  • Common ones: increased urination, menstrual irregularities, breast tenderness or enlargement, and occasional dizziness or headache.
  • Potassium levels may be monitored in older patients or those with certain conditions.
  • Not used in men for acne, due to feminizing effects.
  • Not suitable in pregnancy; contraception is typically advised.

AviClear

  • No systemic effects — no pills, no hormonal changes, no blood monitoring.
  • Suitable for all sexes and all skin tones.
  • Side effects are usually mild and temporary: discomfort during treatment, brief redness, possible transient flare, dryness.
  • Generally avoided in pregnancy as a precaution; contraindicated during skin cancer treatment.

Treatment experience

  • Spironolactone: a daily pill, ongoing, with results building over weeks to a few months. Convenient day to day, but indefinite.
  • AviClear: a short series of in-clinic sessions (about 30 minutes each) with minimal downtime, then no daily routine. Requires visits up front; results build over months.

Cost and access

  • Spironolactone is an inexpensive generic medication and is often covered by insurance, though it’s an ongoing cost for as long as you take it.
  • AviClear is a higher upfront, out-of-pocket cost (generally not insurance-covered), but it’s a finite series rather than an indefinite prescription.

Who might choose which

Spironolactone may fit if you’re a woman with hormonal-pattern acne, are comfortable taking a daily medication, want a low-cost and often insurance-covered option, and aren’t pregnant or planning pregnancy soon.

AviClear may fit if you’re a man (or anyone for whom spironolactone isn’t appropriate), want to avoid daily or hormonal medication, prefer a finite course over an indefinite pill, want a melanin-safe option, or have mild-to-severe inflammatory acne, hormonal or not. These can also be complementary under a clinician’s guidance.

The bottom line

Spironolactone is a well-established, low-cost, generally well-tolerated option with strong evidence for hormonal acne in women, but it’s a daily, indefinite medication that isn’t for everyone. AviClear offers a finite, systemic-side-effect-free, all-skin-tone alternative that targets oil glands directly, with promising but newer evidence and a higher out-of-pocket cost. Your sex, whether your acne is hormonally driven, your feelings about daily medication, and your budget all factor in.

References

  1. Oral spironolactone for acne vulgaris in females: evidence review and practical recommendations. JAAD Reviews, 2025.
  2. Spironolactone for the treatment of acne in women: retrospective study of 110 patients. PMC5440451.
  3. Efficacy and safety of oral spironolactone for women with acne: systematic review and meta-analysis. PMC12359290.
  4. Alexiades M, et al. Novel 1726 nm laser… J Am Acad Dermatol. 2023;89(4):703–710.
  5. Drug dosing, side-effect, and efficacy details, and AviClear figures, should be verified by a clinician before publication.
Houston · Dallas

Acne affecting your skin or your confidence?

Reading is a great start. When you’re ready, a consultation turns this knowledge into a plan built for your skin.

This library is for education only and isn’t a substitute for personalized medical advice. If acne is affecting your skin or your confidence, a consultation with a qualified clinician is the best next step.